The efficacy and safety of oral pharmacokinetically enhanced amoxycillin–clavulanate 2000/125 mg, twice daily, versus oral amoxycillin–clavulanate 1000/125 mg, three times daily, for the treatment of bacterial community-acquired pneumonia in adults
Titel:
The efficacy and safety of oral pharmacokinetically enhanced amoxycillin–clavulanate 2000/125 mg, twice daily, versus oral amoxycillin–clavulanate 1000/125 mg, three times daily, for the treatment of bacterial community-acquired pneumonia in adults
Auteur:
Petitpretz, Patrick Chidiac, Christian Soriano, Francisco Garau, Javier Stevenson, Katharine Rouffiac, Elisabeth
Verschenen in:
International journal of antimicrobial agents
Paginering:
Jaargang 20 (2002) nr. 2 pagina's 11 p.
Jaar:
2002
Inhoud:
Uitgever:
Elsevier Science B.V. and Interantional Society of Chemotherapy.